Market Overview

Higher Prices At Kimberly Clark Are Behind JPMorgan's Higher Rating

Higher Prices At Kimberly Clark Are Behind JPMorgan's Higher Rating

Kimberly Clark Corp (NYSE: KMB)'s announcement that it's raising prices on a host of key items in North America triggered a sell-side upgrade Thursday. 

The Analyst 

JPMorgan analyst Andrea Teixeira upgraded Kimberly Clark from Underweight to Neutral and raised the price target from $90 to $114.

The Thesis

Teixeira estimates that Kimberly Clark’s price increases will apply to roughly 50 percent of its North American personal care business and 85 percent of consumer tissue and take effect in the fourth quarter. (See the analyst's track record here.)

“While it remains to be seen if these price increases will actually hold given the intensely competitive U.S. market, we believe that investors will give KMB shares the benefit of the doubt and that the recent 3x multiple turn rerating that its shares have experienced since early June will likely hold, with the perception that they are turning the corner from the worst,” the analyst said. 

Kimberly Clark said it will raise prices by the mid-single digits to high-single digits on average on Cottonelle, Scott 1000, Kleenex, Viva, Huggies, Pull-Ups and GoodNites.

Competitor Procter & Gamble Co (NYSE: PG)'s recent commentary that it plans to raise prices on some of its premium paper products is supportive of Kimberly Clark’s ability to pass on higher prices, said Teixeira.

“While we believe that KMB may have a bumpy trajectory ahead of it in terms of fully passing list price increases to consumers in [North America], slowing demand in developing markets, FX headwinds and continued pressures from input cost inflation, we think that the recent stock rerating will continue until investors get more visibility on price acceptance in the first half of 2019."

Price Action

Kimberly Clark shares were up 1.48 percent at $118.18 at the time of publication Thursday. 

Related Links:

Cramer Questions Why Apple Trades At Valuation Discount To Procter & Gamble

Jim Cramer Weighs In On Allergan, Procter & Gamble And More

Latest Ratings for KMB

Oct 2020Morgan StanleyMaintainsEqual-Weight
Oct 2020BerenbergInitiates Coverage OnBuy
Oct 2020JefferiesMaintainsBuy

View More Analyst Ratings for KMB
View the Latest Analyst Ratings


Related Articles (KMB)

View Comments and Join the Discussion!

Posted-In: Andrea Teixeira JPMorganAnalyst Color Upgrades Price Target Analyst Ratings Best of Benzinga

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at